Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says
In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored
NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain
Sen. Pryor Attacks Drug Industry, NIH Technology Transfer
Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts
Trial Needed Of PSA To Determine Patients To Test, Chabner Says
DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts
IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









